Merck (MRK) Interest & Investment Income (2010 - 2013)

Merck (MRK) has reported Interest & Investment Income for 4 consecutive years, with $57.0 million the latest figure, recorded in Q1 2013.

• In Q1 2013, Interest & Investment Income rose 3.64% year-over-year to $57.0 million; the TTM figure through Mar 2013 stood at $234.0 million (changed N/A YoY), while the FY2012 annual figure was $232.0 million, up 60.0% from the prior year.
• Interest & Investment Income declined to $57.0 million in Q1 2013 per MRK's latest filing, from $75.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $75.0 million in Q4 2012 and bottomed at $31.0 million in Q4 2010.
• Historically, Interest & Investment Income has averaged $48.6 million across 4 years, with a median of $47.0 million in 2012.
• Annual changes were most pronounced in 2012 — Interest & Investment Income surged 74.42% — and 2013, when it gained 3.64%.
• Merck's Interest & Investment Income stood at $31.0 million in 2010, then soared by 38.71% to $43.0 million in 2011, then soared by 74.42% to $75.0 million in 2012, then dropped by 24.0% to $57.0 million in 2013.
• Business Quant data shows MRK's Interest & Investment Income at $57.0 million in Q1 2013, $75.0 million in Q4 2012, and $47.0 million in Q3 2012.